1. FDA to add alternative approval pathway for medical devices: 4 things to know
The FDA plans to publish a draft guidance during the first quarter of 2018 outlining an alternative pathway for device manufacturers seeking 510(k) clearance.
2. Study: 95.7% of US pharma sales go through primary distributors
Nearly 96 percent of U.S. pharmaceutical sales were brought to the market through pharmaceutical distributors in 2016.
3. The CVS Health-Aetna deal: Are patients winners or losers? How will Amazon and Google react? 8 key questions answered
CVS Health announced plans to acquire Aetna earlier this week for $69 billion, and leaders across healthcare are examining what the deal could mean for the industry going forward.
4. AHA calls on FDA to up its oversight on medical device security
The American Hospital Association penned a letter to the FDA’s Dockets Management staff Dec. 7 encouraging the agency to increase its oversight on medical device security.
5. 10 recent pharma layoffs
Here are 10 drug company layoffs that have occurred in the past two months.
6. Sanofi urges Philippine government to lift suspension of its dengue vaccine
Pharmaceutical giant Sanofi Pasture urged the Philippine government to lift the suspension of its dengue vaccine, arguing it is still safe.
More articles on supply chain:
Eli Lilly forecasts $23B in revenue for 2018
Investor group pushes big pharma to report links between pricing and executive compensation
FDA to add alternative approval pathway for medical devices: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
